Optimisation of T₂*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T.

T₂*-weighted magnetic resonance imaging at 7 T has recently been shown to allow differentiation between white-matter multiple sclerosis lesions and asymptomatic white-matter lesions, by the presence or absence of a detectable central blood vessel. The aim of the present work is to improve the technique by increasing the sensitivity to veins at both 3 T and 7 T, and to assess the benefit of ultra-high-field imaging. Signal-to-noise ratio (SNR) measurements and simulations are used to compare the sensitivity of magnitude T₂*-weighted and susceptibility-weighted images for the detection of small veins (<1 pixel in diameter), both with and without the use of gadolinium. The simulations are used to predict the optimal scanning parameters in order to increase the sensitivity to these veins at both field strengths, and to reduce the inherent dependence on vessel orientation. The sensitivities of the sequences at both field strengths are compared, theoretically and experimentally, in order to quantify the benefit of imaging at ultra-high-field. Subjects with multiple sclerosis (MS) are scanned at both field strengths, using the optimised sequence parameters, as well as those used in previously published work, and the optimisation is shown to improve the detection of veins within lesions.

[1]  Nikos Evangelou,et al.  A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions , 2009, Investigative radiology.

[2]  Jan Sedlacik,et al.  Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results , 2008, Magnetic resonance in medicine.

[3]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[4]  Daniel B. Vigneron,et al.  Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases , 2008, NeuroImage.

[5]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[6]  Richard Bowtell,et al.  T2* measurements in human brain at 1.5, 3 and 7 T. , 2007, Magnetic resonance imaging.

[7]  P. A. Gowland,et al.  Field strength dependence of R1 and R  2* relaxivities of human whole blood to prohance, vasovist, and deoxyhemoglobin , 2008, Magnetic resonance in medicine.

[8]  Yingbiao Xu,et al.  The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. , 2006, Magnetic resonance imaging.

[9]  H Lechner,et al.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis , 1988, Neurology.

[10]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[11]  P. Morgan,et al.  Focal multiple sclerosis lesions abound in ‘normal appearing white matter’ , 2011, Multiple sclerosis.

[12]  Lothar R. Schad,et al.  High-resolution venography of the brain using magnetic resonance imaging , 1998, Magnetic Resonance Materials in Physics, Biology and Medicine.

[13]  H. Brückmann,et al.  Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? , 2011, Neuroradiology.

[14]  Yulin Ge,et al.  Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. , 2008, Archives of neurology.

[15]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[16]  Jullie W Pan,et al.  DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.

[17]  P S Morgan,et al.  Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions , 2011, Neurology.